
Lupin Limited has informed the Exchange regarding a press release dated February 13, 2024, titled "Lupin Launches Bromfenac Ophthalmic Solution, 0.075% in the United States.".
Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated February 13, 2024, titled "Lupin Launches Bromfenac Ophthalmic Solution, 0.075% in the United States.".
6ix hasn’t read this filing yet.
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin